|
⚲
|
| Keyboard |
| Foresite Capital Management V LLC
✚
|
|
|---|---|
| CIK # | 0001792206 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Alumis Inc | 129.9 | ||
| CG Oncology Inc | 68.0 | ||
| FS Development Corp | 23.9 | ||
| Oaktree Acquisition Corp | 15.3 | ||
| Lyell Immunopharma Inc | 9.6 | ||
| Pharvaris NV | 5.5 | ||
| Nurix Therapeutics Inc | 4.1 | ||
| MAZE Therapeutics Inc | 0.8 | ||
| Holdings by Sector ($M) |
|---|
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001792206] | |
| 3 | [0001792206] | |
| 4 | [0001792206] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Eikon Therapeutics Inc EIKN
Series B-1 Preferred Stock · derivative
|
2026-02-04 | Conversion | 282,317 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Series A Preferred Stock · derivative
|
2026-02-04 | Conversion | 10,000,000 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Series C-1 Preferred Stock · derivative
|
2026-02-04 | Conversion | 501,219 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Series C-1 Preferred Stock · derivative
|
2026-02-04 | Conversion | 284,392 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Series D Preferred Stock · derivative
|
2026-02-04 | Conversion | 1,711,025 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Series A-1 Preferred Stock · derivative
|
2026-02-04 | Conversion | 5,204,684 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Series A-1 Preferred Stock · derivative
|
2026-02-04 | Conversion | 2,602,342 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Series B-1 Preferred Stock · derivative
|
2026-02-04 | Conversion | 282,317 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Series B-1 Preferred Stock · derivative
|
2026-02-04 | Conversion | 282,317 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Series D Preferred Stock · derivative
|
2026-02-04 | Conversion | 3,422,051 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Series A-1 Preferred Stock · derivative
|
2026-02-04 | Conversion | 2,502,252 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-04 | Conversion | 1,340,878 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-04 | Buy | 55,555 | $18.00 | 999,990 |
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-04 | Conversion | 37,855 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-04 | Conversion | 229,428 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-04 | Conversion | 697,885 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-04 | Conversion | 37,855 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-04 | Conversion | 1,626 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-04 | Conversion | 67,207 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-04 | Conversion | 458,855 | $0.00 | |
| showing 20 of 115 most recent transactions | |||||